Skip to main content
. Author manuscript; available in PMC: 2016 Aug 17.
Published in final edited form as: Expert Opin Orphan Drugs. 2015 Jun 22;3(8):869–876. doi: 10.1517/21678707.2015.1057498

Figure 1. Patient survival in sporadic and familial DCM.

Figure 1

Analysis of survival free from death and heart transplant (D/HTx) in sporadic (solid line) and non-proband familial DCM (NP-FDC) (dotted line). From Moretti et al., with permission.28